Lin, A., Wei, T., Meng, H., Luo, P., & Zhang, J. (2019). Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. Mol Cancer.
Chicago Style CitationLin, Anqi, Ting Wei, Hui Meng, Peng Luo, i Jian Zhang. "Role of the Dynamic Tumor Microenvironment in Controversies Regarding Immune Checkpoint Inhibitors for the Treatment of Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations." Mol Cancer 2019.
Cita MLALin, Anqi, et al. "Role of the Dynamic Tumor Microenvironment in Controversies Regarding Immune Checkpoint Inhibitors for the Treatment of Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations." Mol Cancer 2019.
Atenció: Aquestes cites poden no estar 100% correctes.